This Phase 1 safety study is to be performed on "12 Princess Alexandra Hospital patients" only.
250k should be plenty.
NB: They've been smart this time with the Phase 1 participant selection. Whereas the HSV study used healthy volunteers, this study will use "patients with head and neck cancer who have had successful chemotherapy and radiation treatment" - i.e. a relevant population
AHZ Price at posting:
25.5¢ Sentiment: Hold Disclosure: Held
